Hypomethylating Agent Maintenance for Favorable and Intermediate Risk Acute Myeloid Leukemia

被引：0
|
作者：
Singh, Reema [1 ]
Halder, Rohan [1 ]
Verma, Megha [1 ]
Mehta, Pallavi [1 ]
Agrawal, Narendra [1 ]
Ahmed, Rayaz [1 ]
Bhurani, Dinesh [1 ]
机构：
[1] Rajiv Gandhi Canc Inst & Res Ctr, Dept Hematooncol & BMT, New Delhi, India
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-162124
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11713 / 11715
页数：3
相关论文
共 50 条
  • [41] Exploring preferences of different modes of administration of hypomethylating agent treatments among patients with acute myeloid leukemia
    Delmas, Audrey
    Batchelder, Laurie
    Arora, Ira
    Bayet, Solene
    Bruhn, David
    Eberhardt, Alice
    Philpott, Stephanie
    Rodriguez-Leboeuf, Ana Maria
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [42] Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease
    Sanber, Khaled
    Ye, Kevin
    Tsai, Hua-Ling
    Newman, Matthew
    Webster, Jonathan A.
    Gojo, Ivana
    Ghiaur, Gabriel
    Prince, Gabrielle T.
    Gondek, Lukasz P.
    Smith, B. Douglas
    Levis, Mark J.
    DeZern, Amy E.
    Ambinder, Alexander J.
    Dalton, William B.
    Jain, Tania
    LEUKEMIA & LYMPHOMA, 2023, 64 (04) : 846 - 855
  • [43] Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective study
    Ludovic Gabellier
    Pierre Peterlin
    Sylvain Thepot
    Yosr Hicheri
    Franciane Paul
    Maria Pilar Gallego-Hernanz
    Sarah Bertoli
    Pascal Turlure
    Arnaud Pigneux
    Romain Guieze
    Marlène Ochmann
    Jean-Valère Malfuson
    Thomas Cluzeau
    Xavier Thomas
    Emmanuelle Tavernier
    Eric Jourdan
    Sarah Bonnet
    Jean-Jacques Tudesq
    Emmanuel Raffoux
    Annals of Hematology, 2024, 103 : 759 - 769
  • [44] Body mass index and venetoclax-hypomethylating agent induction therapy for acute myeloid leukemia.
    Weiss, Julian J.
    Le, Henry
    Agarwal, Sonal
    Podoltsev, Nikolai Alexandrovich
    Zeidan, Amer Methqal
    Shallis, Rory
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] Response to Hypomethylating Agent Therapy in Acute Myeloid Leukemia Based upon Mutations in the DNA Methylation Pathway
    Coombs, Catherine C.
    Devlin, Sean
    Dixit, Shweta
    Mohanty, Abhinita
    Knapp, Kristina Marie
    Arcila, Maria
    Klimek, Virginia M.
    Tallman, Martin S.
    Levine, Ross L.
    Rampal, Raajit K.
    Rapaport, Franck
    BLOOD, 2015, 126 (23)
  • [46] Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naive acute myeloid leukemia
    Gangat, Naseema
    Johnson, Isla
    McCullough, Kristen
    Farrukh, Faiqa
    Al-Kali, Aref
    Alkhateeb, Hassan
    Begna, Kebede
    Mangaonkar, Abhishek
    Litzow, Mark
    Hogan, William
    Shah, Mithun
    Patnaik, Mrinal
    Pardanani, Animesh
    Tefferi, Ayalew
    HAEMATOLOGICA, 2022, 107 (10) : 2501 - 2505
  • [47] Outcomes By Best Response with Hypomethylating Agent Plus Venetoclax in Adults with Previously Untreated Acute Myeloid Leukemia
    Volpe, Virginia Olivia
    Jain, Akriti G.
    Chan, Onyee
    Padron, Eric
    Sallman, David A.
    Komrokji, Rami S.
    Lancet, Jeffrey E.
    Sweet, Kendra
    BLOOD, 2021, 138
  • [48] Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemia
    Jain, Akriti G.
    Volpe, Virginia O.
    Wang, Chen
    Ball, Somedeb
    Tobon, Katherine
    Chan, Onyee
    Padron, Eric
    Kuykendall, Andrew
    Lancet, Jeffrey E.
    Komrokji, Rami
    Sallman, David A.
    Sweet, Kendra L.
    ANNALS OF HEMATOLOGY, 2025, 104 (01) : 307 - 315
  • [49] Hypomethylating agent for acute myeloid leukemia, the efficacy and its effect towards mortality rate: Systematic review
    Tandokallo, Felicia
    Jhoputri, Caroline Fricilia
    Kosayuz, Sherina
    Atmaja, William Surya
    Kurniawan, Andree
    ANNALS OF ONCOLOGY, 2023, 34 : S1446 - S1446
  • [50] Hypomethylating Agent and Venetoclax in Newly Diagnosed and Relapsed CBF/::MYH11(+) Acute Myeloid Leukemia
    Feng, Ziyu
    Hu, Xiaohui
    Li, Weiyang
    Xu, Ting
    Xu, Yang
    Xue, Shengli
    Qiu, Huiying
    Tang, Xiaowen
    Han, Yue
    Chen, Suning
    Sun, Aining
    Wu, Depei
    Wang, Ying
    BLOOD, 2024, 144 : 4287 - 4288
12345